4.6 Review

Regulation of the Hippo Pathway Transcription Factor TEAD

期刊

TRENDS IN BIOCHEMICAL SCIENCES
卷 42, 期 11, 页码 862-872

出版社

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2017.09.003

关键词

-

资金

  1. National Institutes of Health [CA196878, DE15964, GM51586]
  2. Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI17C1560]
  3. National Research Foundation of Korea (NRF) grant - Korea government (MOE) [2017R1D1A1B03034797]
  4. National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1A4A1015328]
  5. University of California, San Diego (UCSD) Graduate Training Program in Cellular and Molecular Pharmacology [T32 GM007752]
  6. National Research Foundation of Korea [2017R1D1A1B03034797, 2017R1A4A1015328] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The TEAD transcription factor family is best known for transcriptional output of the Hippo signaling pathway and has been implicated in processes such as development, cell growth and proliferation, tissue homeostasis, and regeneration. Our understanding of the functional importance of TEADs has increased dramatically since its initial discovery three decades ago. The majority of our knowledge of TEADs is in the context of Hippo signaling as nuclear DNA-binding proteins passively activated by Yes-associated protein (YAP) and transcriptional activator with PDZ-binding domain (TAZ), transcription coactivators downstream of the Hippo pathway. However, recent studies suggest that TEAD itself is actively regulated. Here, we highlight evidence demonstrating Hippo-independent regulation of TEADs and the potential impacts these studies may have on new cancer therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据